55 results
8-K
EX-10.1
NMTC
NeuroOne Medical Technologies Corp
14 Nov 23
Volker strengthens existing management team in areas of commercialization, business development, and reimbursement
5:28pm
or inducement has been made to Employee, (ii) Employee has relied on Employee’s own judgment and investigation in accepting Employee’s employment
8-K
EX-5.1
NMTC
NeuroOne Medical Technologies Corp
27 Jul 23
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
4:02pm
of such documents as we deemed relevant. In conducting our examination, we assumed, without investigation, the genuineness of all signatures, the correctness
8-K
EX-1.1
NMTC
NeuroOne Medical Technologies Corp
27 Jul 23
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
4:02pm
after reasonable investigation.
- 2 -
(ii) Accurate Disclosure. Each Preliminary Prospectus, at the time of filing thereof or the time of first use … ; and the Company has no knowledge of any pending investigation which might lead to such a claim nor is the Company anticipating incurring any material capital
8-K
EX-1.1
uimkt 4i2ebsezf8l1
14 Oct 21
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
9:00am
8-K
EX-5.1
glapiwsn f7ytbq
14 Oct 21
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
9:00am
S-3
EX-4.7
abcaec zvg38
4 Jun 21
Shelf registration
5:19pm
8-K
EX-10.1
0oqjas6jh9xv4xp
15 Jan 21
NeuroOne Medical Technologies Corporation Announces Private Placement
8:08am
8-K
EX-10.1
d939irij85v61d
7 Jan 21
NeuroOne Medical Technologies Corporation Appoints Ronald McClurg, Experienced Financial Industry Executive, as Chief Financial Officer
8:59am
POS AM
EX-5.1
lrzmtd7fdty
30 Sep 20
Prospectus update (post-effective amendment)
12:00am